Journals / Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.) / 2011 / Cilt: 22 - Sayı: 1

Siklooksijenaz-2 (COX-2/PTGS2) gen polimorfizmi ile osteoartrit arasındaki ilişki

The association between cyclooxygenase-2 (COX-2/PTGS2) gene polymorphism and osteoarthritis

Pages
22–27
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Furthermore, this study presents the first results of COX-2 promoter variant in Turkish patients with osteoarthritis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to investigate the relationship between the risk for the development of osteoarthritis and Cyclooxygenase-2 (COX 2) -765G>C gene polymorphism.
📊
Key Findings & Data:Patients and methods: We included a total of 100 osteoarthritis patients (18 males, 82 females; mean age 60.4±8.4 years; range 41 to 81 years) who were treated in the Physical Therapy Clinic and 100 healthy subjects without a history of arthritis (40 males, 60 females; mean age 30.9±7.5 years; range 16 to 48 years) in our study between September 2006 and May 2008.
💡
Conclusion & Impact:Furthermore, this study presents the first results of COX-2 promoter variant in Turkish patients with osteoarthritis.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aims to investigate the relationship between the risk for the development of osteoarthritis and Cyclooxygenase-2 (COX 2) -765G>C gene polymorphism. Patients and methods: We included a total of 100 osteoarthritis patients (18 males, 82 females; mean age 60.4±8.4 years; range 41 to 81 years) who were treated in the Physical Therapy Clinic and 100 healthy subjects without a history of arthritis (40 males, 60 females; mean age 30.9±7.5 years; range 16 to 48 years) in our study between September 2006 and May 2008. The frequency of -765G>C gene polymorphism in the COX-2 promoter region was investigated in the osteoarthritis patients and the control group without a history of arthritis using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The data were analysed with chi-square and logistic regression analysis. Results: The frequencies of -765G>C polymorphism for GG, GC and CC genotypes were found to be 54%, 35%, and 11% in the control group and 48%, 34% and 18% in the osteoarthritis group, respectively. Conclusion: Based on the data obtained, it can be stated that there is no significant relation between COX-2 -765G>C polymorphism and osteoarthritis disease. Furthermore, this study presents the first results of COX-2 promoter variant in Turkish patients with osteoarthritis.

Özet

Amaç: Çalışmada osteoartrit hastalığının gelişme riski ile Cyclooxygenase-2 (COX 2) -765G>C gen polimorfizmi arasındaki ilişki araştırıldı. Hastalar ve yöntemler: Eylül 2006 - Mayıs 2008 tarihleri arasında Fizik Tedavi Kliniğinde tedavi edilen osteoartritli 100 hasta (18 erkek, 82 kadın; ort. yaş 60.4±8.4 yıl; dağılım 41-81 yıl) ve artrit öyküsü bulunmayan 100 sağlıklı gönüllü (40 erkek, 60 kadın; ort. yaş 30.9±7.5 yıl; dağılım 16-48 yıl) çalışmaya alındı. Cyclooxygenase-2 promoter bölgesindeki -765G>C gen bölgesinin-polimorfizminin sıklığı osteoartritli hastalarda ve artrit öyküsü bulunmayan kontrol grubunda polimeraz zincir reaksiyonu-restriksiyon parça uzunluk polimorfizmi (PCR-RFLP) yöntemi kullanılarak araştırıldı. Veriler ki-kare ve lojistik regresyon analizi ile analiz edildi. Bulgular: GG, GC ve CC genotiplerine ilişkin -765G>C polimorfizmi sıklığının kontrol grubunda sırasıyla %54, %35 ve %11, osteoartrit grubunda ise sırasıyla %48, %34 ve %18 olduğu tespit edildi. Sonuç: Elde edilen verilere göre, COX-2 -765G>C polimorfizmi ile osteoartrit hastalığı arasında anlamlı bir ilişki bulunmadığı söylenebilir. Ayrıca bu çalışmada osteoartritli Türk hastalardaki COX-2 promoter varyantı konusunda ilk bulgular sunulmaktadır.

🔖

Cite This Article

BERKÖZ, M., YALIN, E., ÇİMEN, Ö. B., EROĞLU, P., YALIN, S., KANIK, A., GÜLER, V. G. (2022). Siklooksijenaz-2 (COX-2/PTGS2) gen polimorfizmi ile osteoartrit arasındaki ilişki. Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.), Cilt: 22 - Sayı: 1, 22–27. https://ajindex.com/articles/498689

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Molloy ES, McCarthy GM. Eicosanoids, osteoarthritis, and crystal deposition diseases. Curr Opin Rheumatol 2005;17:346-50
  2. Valdes AM, Loughlin J, Timms KM, van Meurs JJ, Southam L, Wilson SG, et al. Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis. Am J Hum Genet 2008;82:1231-40
  3. Martel-Pelletier J, Pelletier JP. Is osteoarthritis a disease involving only cartilage or other articular tissues? Eklem Hastalik Cerrahisi 2010;21:2-14
  4. Kalacı A, Uz E, Aslan B, Söğüt S, Özkan C, Yanat AN. Nitric oxide levels and superoxide dismutase enzyme activity in synovial fluid of patients with knee osteoarthritis. Eklem Hastalık Cerrahisi 2007;18:13-7
  5. Maxis K, Delalandre A, Martel-Pelletier J, Pelletier JP, Duval N, Lajeunesse D. The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein. Arthritis Res Ther 2006;8:R181
  6. Raisz LG. Prostaglandins and bone: physiology and pathophysiology. Osteoarthritis Cartilage 1999;7:419-21
  7. Martel-Pelletier J, Pelletier JP, Fahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum 2003;33:155-67
  8. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, et al. Cyclooxygenase in biology and disease. FASEB J 1998;12:1063-73
  9. Willoughby DA, Moore AR, Colville-Nash PR. COX-1, COX- 2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet 2000;355:646-8
  10. Kojima F, Kato S, Kawai S. Prostaglandin E synthase in the pathophysiology of arthritis. Fundam Clin Pharmacol 2005;19:255-61
  11. Vuolteenaho K, Moilanen T, Moilanen E. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process. Basic Clin Pharmacol Toxicol 2008;102:10-4
  12. Papafili A, Hill MR, Brull DJ, McAnulty RJ, Marshall RP, Humphries SE, et al. Common promoter variant in cyclooxygenase- 2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 2002;22:1631-6
  13. Cipollone F, Toniato E, Martinotti S, Fazia M, Iezzi A, Cuccurullo C, et al. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA 2004;291:2221-8
  14. Hill MR, Papafili A, Booth H, Lawson P, Hubner M, Beynon H, et al. Functional prostaglandin-endoperoxide synthase 2 polymorphism